Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v13-FR
Language English French
Date Updated 2023-07-05 2023-06-09
Drug Identification Number 00406716 00406716
Brand name NOVAMOXIN NOVAMOXIN
Common or Proper name TEVA-AMOXICILLIN TEVA-AMOXICILLIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients AMOXICILLIN AMOXICILLIN
Strength(s) 500MG 500MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100,500 100,500
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-01 2022-12-01
Estimated end date 2023-06-30 2023-06-30
Actual end date 2023-07-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments